Neuropathic pain phenotype does not involve the NLRP3 inflammasome and its end product interleukin-1β in the Mice spared nerve injury model

31Citations
Citations of this article
49Readers
Mendeley users who have this article in their library.

Abstract

The NACHT, LRR and PYD domains-containing protein 3 (NLRP3) inflammasome is one of the main sources of interleukin-1β (IL-1β) and is involved in several inflammatory-related pathologies. To date, its relationship with pain has not been studied in depth. The aim of our study was to elucidate the role of NLRP3 inflammasome and IL-1β production on neuropathic pain. Results showed that basal pain sensitivity is unaltered in NLRP3-/-mice as well as responses to formalin test. Spared nerve injury (SNI) surgery induced the development of mechanical allodynia and thermal hyperalgesia in a similar way in both genotypes and did not modify mRNA levels of the NLRP3 inflammasome components in the spinal cord. Intrathecal lipopolysaccharide (LPS) injection increases apoptosis-Associated speck like protein (ASC), caspase-1 and IL-1β expression in both wildtype and NLRP3-/-mice. Those data suggest that NLRP3 is not involved in neuropathic pain and also that other sources of IL-1β are implicated in neuroinflammatory responses induced by LPS. Copyright:

Cite

CITATION STYLE

APA

Curto-Reyes, V., Kirschmann, G., Pertin, M., Drexler, S. K., Decosterd, I., & Suter, M. R. (2015). Neuropathic pain phenotype does not involve the NLRP3 inflammasome and its end product interleukin-1β in the Mice spared nerve injury model. PLoS ONE, 10(7). https://doi.org/10.1371/journal.pone.0133707

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free